Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KNC Laboratories Co's EBIT per Share for the
six
months ended in Mar. 2026 was 円133.87.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円136.97.
During the past 12 months, the average EBIT per Share Growth Rate of KNC Laboratories Co was 32.50% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -22.10% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 3.90% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 7.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for KNC Laboratories Co's EBIT per Share or its related term are showing as below:
TSE:6568'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -25.9 Med: -7.55 Max: 58.6
Current: -22.1
During the past 11 years, the highest 3-Year average EBIT per Share Growth Rate of KNC Laboratories Co was 58.60% per year. The lowest was -25.90% per year. And the median was -7.55% per year.
TSE:6568's 3-Year EBIT Growth Rate is ranked worse than 77.82% of 1339
companies
in the Chemicals industry
Industry Median: -1.2
vs TSE:6568: -22.10
KNC Laboratories Co (TSE:6568) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
KNC Laboratories Co EBIT per Share Related Terms
KNC Laboratories Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for KNC Laboratories Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円136.97
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KNC Laboratories Co (TSE:6568) has a EBIT per Share of 円136.97 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on KNC Laboratories Co and its competitors. According to the industry distribution chart, KNC Laboratories Co ranks #1042 out of 1339 companies in the Chemicals industry, placing it in the top 77.8%.
Is KNC Laboratories Co's EBIT per Share too high?
KNC Laboratories Co's current EBIT per Share is 円136.97. Based on the distribution chart, KNC Laboratories Co ranks #1042 out of 1339 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, KNC Laboratories Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KNC Laboratories Co's EBIT per Share compare to DOW?
According to the Chemicals industry distribution chart, KNC Laboratories Co ranks #1042 out of 1339 companies for EBIT per Share. This places KNC Laboratories Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on KNC Laboratories Co and its competitors. KNC Laboratories Co's current EBIT per Share is 円136.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KNC Laboratories Co stock overvalued right now?
Based on GuruFocus' analysis, KNC Laboratories Co (TSE:6568) is currently considered Fairly Valued. The stock's GF Value™ is 円1,294.38, compared to a current price of 円1,296.00 — trading 0.1% above its estimated fair value. The current EBIT per Share is 円136.97. KNC Laboratories Co's overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For KNC Laboratories Co (TSE:6568), the current EBIT per Share is 円136.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KNC Laboratories Co (TSE:6568) Overvalued in 2026?
Based on GuruFocus' analysis, KNC Laboratories Co stock appears to be overvalued.
The current stock price of 円1,296.00 is trading 0.1% above its estimated GF Value™ of 円1,294.38.
GuruFocus considers KNC Laboratories Co to be Fairly Valued.
Key valuation signals for TSE:6568:
EBIT per Share: 円136.97
GF Value™: 円1,294.38 vs. price of 円1,296.00 (0.1% above fair value)
No single metric tells the full story. See the TSE:6568 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6568 has been successfully added to your 
